Literature DB >> 29124816

The Cannabis Abuse Screening Test and the DSM-5 in the general population: Optimal thresholds and underlying common structure using multiple factor analysis.

Stéphane Legleye1,2.   

Abstract

The Cannabis Abuse Screening Test (CAST) aims at screening the problematic use of cannabis. It has never been validated against the Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 and its relationships with this latter have never been studied. We used a probabilistic telephone survey collected in 2014 (1351 past-year cannabis users aged 15-64) implementing the CAST and a DSM-5 adaptation of the Munich Composite International Diagnostic Interview assessing cannabis use disorders. Data were weighted, and CAST items were considered categorical. Factorial structures were assessed with confirmatory factor analyses; the relationships between the instruments were studied with multiple factor analysis (MFA). One factor for the DSM-5 and two correlated factors for the CAST were the best confirmatory factor analyses solutions. The CAST thresholds for screening moderate/severe and severe cannabis use disorders were 5 (sensitivity = 78.2% and specificity = 79.6%) and 8 (sensitivity = 86.0% and specificity = 86.7%), respectively. The MFA identified two orthogonal dimensions: The first was equally shared by both instruments; the second was the second CAST dimension (extreme frequencies of use before midday and alone, memory problems, and reproaches from friends/family). The CAST structure and screening properties were confirmed. The MFA explains its screening performances by its first dimension and identified the problematic patterns (the second dimension) that are not captured by the DSM-5.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  CAST; CFA; DSM-5; cannabis problematic use; multiple factor analysis; validation

Mesh:

Year:  2017        PMID: 29124816      PMCID: PMC6877270          DOI: 10.1002/mpr.1597

Source DB:  PubMed          Journal:  Int J Methods Psychiatr Res        ISSN: 1049-8931            Impact factor:   4.035


  28 in total

1.  The structure of cannabis dependence in the community.

Authors:  Maree Teesson; Michael Lynskey; Barry Manor; Andrew Baillie
Journal:  Drug Alcohol Depend       Date:  2002-12-01       Impact factor: 4.492

2.  Revising the Cannabis Use Disorders Identification Test (CUDIT) by means of Item Response Theory.

Authors:  Beatrice Annaheim; Thomas J Scotto; Gerhard Gmel
Journal:  Int J Methods Psychiatr Res       Date:  2010-09       Impact factor: 4.035

3.  The validity of DSM-IV cannabis abuse and dependence criteria in adolescents and the value of additional cannabis use indicators.

Authors:  Daniela Piontek; Ludwig Kraus; Stéphane Legleye; Gerhard Bühringer
Journal:  Addiction       Date:  2011-03-07       Impact factor: 6.526

4.  Psychometric properties of the Cannabis Abuse Screening Test in Hungarian samples of adolescents and young adults.

Authors:  Aron Gyepesi; Róbert Urbán; Judit Farkas; Ludwig Kraus; Daniela Piontek; Borbála Paksi; Gergely Horváth; Anna Magi; Andrea Eisinger; János Pilling; Gyöngyi Kökönyei; Bernadette Kun; Zsolt Demetrovics
Journal:  Eur Addict Res       Date:  2013-11-06       Impact factor: 3.015

5.  The Cannabis Abuse Screening Test (CAST) revisited: examining measurement invariance by age.

Authors:  Sharon R Sznitman
Journal:  Int J Methods Psychiatr Res       Date:  2016-10-10       Impact factor: 4.035

6.  The Cannabis Abuse Screening Test and the DSM-5 in the general population: Optimal thresholds and underlying common structure using multiple factor analysis.

Authors:  Stéphane Legleye
Journal:  Int J Methods Psychiatr Res       Date:  2017-11-10       Impact factor: 4.035

7.  Does gender contribute to heterogeneity in criteria for cannabis abuse and dependence? Results from the national epidemiological survey on alcohol and related conditions.

Authors:  Arpana Agrawal; Michael T Lynskey
Journal:  Drug Alcohol Depend       Date:  2006-11-03       Impact factor: 4.492

Review 8.  Structure, content and reliability of the Munich-Composite International Diagnostic Interview (M-CIDI) substance use sections.

Authors:  G Lachner; H U Wittchen; A Perkonigg; A Holly; P Schuster; U Wunderlich; D Türk; E Garczynski; H Pfister
Journal:  Eur Addict Res       Date:  1998-03       Impact factor: 3.015

9.  Screening of cannabis-related problems among youth: the CPQ-A-S and CAST questionnaires.

Authors:  Sergio Fernandez-Artamendi; José Ramón Fernández-Hermida; José Muñiz-Fernández; Roberto Secades-Villa; Gloria García-Fernández
Journal:  Subst Abuse Treat Prev Policy       Date:  2012-04-02

Review 10.  Short scales to assess cannabis-related problems: a review of psychometric properties.

Authors:  Daniela Piontek; Ludwig Kraus; Danica Klempova
Journal:  Subst Abuse Treat Prev Policy       Date:  2008-12-02
View more
  11 in total

1.  The Cannabis Abuse Screening Test and the DSM-5 in the general population: Optimal thresholds and underlying common structure using multiple factor analysis.

Authors:  Stéphane Legleye
Journal:  Int J Methods Psychiatr Res       Date:  2017-11-10       Impact factor: 4.035

2.  Central Oxidative Stress and Early Vocational Outcomes in First Episode Psychosis: A 7-Tesla Magnetic Resonance Spectroscopy Study of Glutathione.

Authors:  Michael MacKinley; Sabrina D Ford; Peter Jeon; Jean Théberge; Lena Palaniyappan
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

3.  The mediating effect of anger rumination, coping and conformity motives on the association between hostility and problematic cannabis use.

Authors:  Zsolt Horváth; Gyöngyi Kökönyei; Péter Sárosi; Mónika Koós; Zsolt Demetrovics; Róbert Urbán
Journal:  Addict Behav Rep       Date:  2022-07-09

4.  The gendered relationship between illicit substance use and self-harm in university students.

Authors:  Nicole G Hammond; Børge Sivertsen; Jens Christoffer Skogen; Simon Øverland; Ian Colman
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-01-16       Impact factor: 4.519

5.  Guided web-based treatment program for reducing cannabis use: a randomized controlled trial.

Authors:  Kristina Sinadinovic; Magnus Johansson; Ann-Sofie Johansson; Thomas Lundqvist; Philip Lindner; Ulric Hermansson
Journal:  Addict Sci Clin Pract       Date:  2020-02-18

6.  Cannabis use among Norwegian university students: Gender differences, legalization support and use intentions, risk perceptions, and use disorder.

Authors:  Jasmina Burdzovic Andreas; Børge Sivertsen; Kari Jussie Lønning; Jens Christoffer Skogen
Journal:  Addict Behav Rep       Date:  2021-01-15

7.  Association patterns of cannabis abuse and dependence with risk of problematic non-substance-related dysregulated and addictive behaviors.

Authors:  José C Perales; Antonio Maldonado; Eva M López-Quirantes; Francisca López-Torrecillas
Journal:  PLoS One       Date:  2021-08-10       Impact factor: 3.240

8.  Prevalence and associated factors of cannabis consumption in medical students: the BOURBON nationwide study.

Authors:  Guillaume Fond; A Picot; A Bourbon; M Boucekine; P Auquier; C Lançon; L Boyer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-05-05       Impact factor: 5.270

9.  Measuring individual benefits of psychiatric treatment using longitudinal binary outcomes: Application to antipsychotic benefits in non-cannabis and cannabis users.

Authors:  Xuan Zhang; Jose de Leon; Benedicto Crespo-Facorro; Francisco J Diaz
Journal:  J Biopharm Stat       Date:  2020-06-08       Impact factor: 1.503

10.  The Effects of E-Cigarette Use on Alcohol and Marijuana Abuse Symptoms in an Ethnically Diverse Sample of Young Adults.

Authors:  Pallav Pokhrel; Taha Elwir; Hannah Mettias; Crissy T Kawamoto; Nabin Oli; Scott K Okamoto
Journal:  Int J Environ Res Public Health       Date:  2021-12-14       Impact factor: 4.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.